Drug Infusion Systems Market Expected to Experience Significant Expansion with 8.90% CAGR Reaching $24.04 Billion by the year 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Drug Infusion Systems Market- by Product (Large Volume Infusion Systems, Patient-Controlled Analgesia, Elastomeric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Systems, Implantable Infusion Systems, Ambulatory Infusion Systems and Enteral Infusion Systems), Application (Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Haematology, Paediatrics and Other Applications), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1271

According to the latest research by InsightAce Analytic, the global Drug Infusion Systems market is valued at US$ 11.64 billion in 2021, and it is expected to reach 24.04 Billion by the year 2031, with a CAGR of 8.90% during a forecast period of 2024-2031.

An infusion system, typically in the form of a pump, is used to administer fluids, nutrients, or medications directly into a patient's circulatory system. While these systems are occasionally employed for epidural and arterial infusions, they are most commonly used for intravenous administration, particularly for managing conditions that affect the nervous system. Drug infusion systems are widely utilized across various therapeutic areas to facilitate the intravenous or non-oral delivery of pharmaceuticals, such as antibiotics, chemotherapeutic agents, insulin, and opioids.

The global market for drug infusion systems is poised for significant growth, driven by the increasing demand for safe and accurate drug delivery solutions and the rising prevalence of chronic diseases and disorders worldwide. These systems are designed to administer precise dosages of medication, with technology that calculates and displays the appropriate dosage for healthcare providers. The ability of infusion systems to deliver medications safely and precisely is expected to further promote their adoption within the healthcare industry. Additionally, the growing use of infusion systems for the management of chronic pain, particularly in the treatment of conditions like diabetes, is likely to drive market growth. The demand for infusion systems for hemodynamic control is also anticipated to contribute to the continued expansion of the drug infusion systems market in the forecast period.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

North America is projected to be the leading contributor to the Drug Infusion Systems market in the coming years, driven by the increasing prevalence of chronic diseases in countries such as the United States and Canada. Additionally, the growing number of procedures performed in hospitals is expected to further support market expansion in the region. Meanwhile, the Asia Pacific market for Drug Infusion Systems is anticipated to experience significant growth during the forecast period. This growth is attributed to the rising incidence of diabetes and cancer across countries in the region. Moreover, increased government investments in healthcare, aimed at adopting advanced medical technologies, are expected to drive the market's growth in Asia Pacific in the near future.

Major market players operating in the Drug Infusion Systems market include
Acromed AG, B. Braun Melsungen AG, Becton, Dickinson and Company, Baxter International Inc., Caesarea Medical Electronics Ltd., Flowonix Medical Inc., Fresenius SE & Co. KGaA, Debiotech S.A., Halyard Health, Inc., IRADIMED CORPORATION, Insulet Corporation, Medtronic, ICU Medical Inc., MOOG, Inc., Smiths Group plc, Tandem Diabetes Care, Inc., Terumo Corporation and Zyno Medical, LLC among others.

Recent collaborations and agreements in the market:
• In August 2021, Smiths Medical and Ivenix announced a collaboration on best-in-class infusion management technology to improve the infusion administration process.
• In July 2021, Innovative Health Sciences announced the CE mark for a syringe infusion system.
• In May 2020,International Baxter Inc. The Evo IQ Infusion System has acquired CE certification and regulatory approval from Australia's Therapeutic Goods Administration, according to Baxter International Inc., a global pioneer in advanced drug delivery technology (TGA). With the release of the Evo IQ Infusion System, there is now a wider range of infusion therapy options for different types of patients.
• In January 2020, Medtronic (Ireland) released Efficio, a cloud-based data management software designed to work with the SynchroMed II intrathecal medication delivery system. This allows clinicians to manage their targeted medication delivery pump procedures more efficiently while treating patients with chronic pain, cancer, and severe spasticity.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1271

Market Segments
Global Drug Infusion Systems Market, by Product Type, 2022-2030 (Value US$ Mn)
• Large Volume Infusion Systems
• Patient-Controlled Analgesia
• Elastomeric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Systems
• Implantable Infusion Systems
• Ambulatory Infusion Systems
• Enteral Infusion Systems
Global Drug Infusion Systems Market, by Application, 2022-2030 (Value US$ Mn)
• Oncology/Chemotherapy
• Diabetes
• Analgesia
• Nutrition
• Haematology
• Paediatrics
• Other Applications
Global Drug Infusion Systems Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Drug Infusion Systems Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Drug Infusion Systems market
 To receive an industry overview and future trends of the Drug Infusion Systems market
 To analyze the Drug Infusion Systems market drivers and challenges
 To get information on the Drug Infusion Systems market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Drug Infusion Systems market industry

Read Overview Report- https://www.insightaceanalytic.com/report/global-drug-infusion-systems-market/1271

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.